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Background & Aims 
Weight loss is common in people with neurodegenerative diseases of the motor system 
(NDMS), such as Parkinson’s disease and Amyotrophic Lateral Sclerosis, and is associated 
with reduced quality of life, functional ability and survival. This systematic review aims to 
identify interventions and intervention components (i.e. behaviour change techniques [BCTs] 
and modes of delivery [MoDs]) that are associated with increased effectiveness in promoting 
oral nutritional behaviours that help people with NDMS to achieve a high-calorie diet. 
Methods 
Eight electronic databases including MEDLINE and CINAHL were searched from inception 
to May 2018.  All interventions from included studies were coded for relevant BCTs and 
MoDs. Methodological quality of studies was assessed using the Cochrane risk of bias tool. 
Results 
Fourteen studies were included. Of these, eight studies reported interventions to assist with 
swallowing difficulties and six studies reported interventions targeting dietary content. 
Beneficial effects in managing swallowing difficulties were observed with video assisted 
swallowing therapy, lung volume recruitment and swallowing management clinics with 
outpatient support. In contrast, studies reporting effectiveness of chin down posture, use of 
thickened liquids and respiratory muscle training were inconclusive. Positive effects in 
interventions targeting dietary content included the use of food pyramid tools, individualised 
nutritional advice with nutritional interventions, electronic health applications, face-to-face 
dietary counselling and high fat, high carbohydrate and milk whey protein supplements. 
Individualised nutritional advice with weekly phone contact did not appear to be effective. 
Most frequently coded BCTs were ‘instructions on how to perform the behaviour’, ‘self-




‘human’, ‘face-to-face’ and ‘somatic therapy’. However, the robustness of these findings are 
low due to small number of studies, small sample sizes and large between-study variability. 
Conclusions 
Despite the limited evidence, these findings may help inform the development of more 
effective interventions to promote oral nutritional behaviours in people with NDMS. 
However, further research is needed to demonstrate which interventions, or intervention 
components, yield most benefit. 
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Weight loss is a common problem in neurodegenerative disorders of the motor system 
(NDMS, e.g. Parkinson’s disease (PD), Amyotrophic Lateral Sclerosis (ALS), Huntington’s 
disease (HD), Progressive Supranuclear Palsy) and may occur due to a number of factors 
including dysphagia, loss of appetite, progressive weakness of limb muscles and respiratory 
muscles, difficulty in handling utensils, and increased energy expenditure due to a 
hypermetabolic state.1-6 Weight loss is well recognised as a poor prognostic factor in people 
with NDMS.7 For instance in PD, early weight loss is associated with greater risk of 
dementia, loss of independency and premature death.8 Similarly in ALS, body mass index 
(BMI) is an independent predictor of survival, with mild obesity having a protective effect 
and lower BMI associated with a worse prognosis.9 Such findings point to the importance of 
maintaining or increasing body weight, particularly in the early stages of the disease, in order 
to improve survival, functional ability and quality of life in people with NDMS. Therefore 
there is a clear need for interventions that help people with NDMS to achieve a high calorie 
diet to maintain or increase their weight and overcome eating-related barriers (e.g. dysphagia, 
loss of appetite) that are associated with poorer nutritional outcomes (e.g. weight loss, 
malnutrition). However, the evidence base in this area is lacking. Reviews in ALS have 
largely focused on interventions such as enteral feeding (via nasogastric tubes or 
gastrostomy) when patients are unable to safely maintain an adequate oral intake,10 rather 
than on the use of oral nutritional interventions (e.g. food fortification, oral nutritional 
supplements) in early stages of the disease. Reviews in PD have discussed a range of 
nutritional issues but have not considered the effectiveness of nutritional interventions.11 





The aim of this systematic review was to identify studies on the effectiveness of oral 
nutritional interventions to help people with NDMS achieve a high calorie diet. In addition, 
the review sought to identify any intervention components (i.e. behaviour change techniques) 
and modes of delivery that are associated with greater effectiveness. 
 
Methods 
This systematic review was reported in accordance with the general principles recommended 
in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
statement.12 A protocol was developed and registered on the PROSPERO international 
prospective register of systematic reviews 
(http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018105902). 
 
Data sources and searches 
Systematic searches were undertaken in relevant electronic databases and research registers 
including MEDLINE, MEDLINE in Process, EMBASE, the Cochrane Library, CINAHL, 
PsychINFO and Web of Science. The search strategy used a combination of subject headings 
and free text terms (e.g. food, fortified/; dietary supplements/; ONS; oral nutrition* 
supplement*; high calori*; patient compliance/adherence) combined with keywords for 
NDMSs (e.g. ALS or Motor Neurone Disease or Parkinson’s disease or Huntington’s Disease 
or Progressive Supranuclear Palsy etc.) to identify papers that examined factors associated 
with nutritional behaviours and outcomes in people with NDMS. A filter to identify 
intervention studies (by the inclusion of terms such as intervention, randomized controlled 
trial, RCT, cluster trial) was subsequently applied. Due to lack of evidence identified in 
relation to dietary and nutritional advice and counselling, targeted follow-up searches were 




counselling”. Databases were searched from inception to May 2018 for the main searches, 
and to August 2018 for the targeted searches. No language or date restrictions were applied.  
Searches were supplemented by hand-searching the reference lists of relevant reviews and 
included studies, citation searching and contact with experts in the field. Details of the search 
strategies are provided in Supplementary Appendix 2. 
 
Study selection 
All titles were examined for inclusion by one reviewer and any citations that clearly did not 
meet the inclusion criteria (e.g. non-human, unrelated to nutrition behaviour) were excluded. 
All abstracts and full text articles were then examined independently by two reviewers. Any 
disagreements in the selection process were resolved by discussion, with involvement of a 
third reviewer when necessary. A summary of the inclusion and exclusion criteria is 
presented in Table 1.  
 
Data abstraction  
Data relating to study design, patient characteristics and outcomes were extracted by one 
reviewer into a standardised data extraction form, and independently checked for accuracy by 
a second reviewer. Any discrepancies were resolved by discussion, with involvement of a 
third reviewer, if required. Identified intervention components were coded according to the 
Behaviour Change Techniques (BCTs) taxonomy13 and the Modes of Delivery (MoDs) 
classification.14 The coding was undertaken by one reviewer and independently checked by 
another. Any disagreement was resolved by discussion. Definitions of the BCTs and MoDs 






Table 1  
Study selection criteria. 
 INCLUSION CRITERIA EXCLUSION CRITERIA 
Population  Adults (aged > 18 years) with NDMS  i.e. 
MNDs, ALS, PD, HD, PSP, PBP, PMA, PLS, 
or Kennedy’s disease (at any stage of disease) 
People without NDMS, healthy volunteers, 
children (aged <18 years) and studies in 
animals 
Intervention  Any interventions delivered to individuals (to 
change their beliefs, knowledge, skills, etc.) to 
promote nutritional behaviour (e.g. uptake of 
oral nutritional supplement, food fortification) 
OR eating behaviour (e.g. swallowing, use of 
adapted cutlery) to achieve a high calorie diet. 
Studies on tube feeding/gastrostomy, other 
dietary supplements (e.g. vitamins, minerals 
and herbs), drug interventions, acupuncture, 
transcranial direct current stimulation (TDCS) 
etc. 
Studies not on nutritional or eating behaviour 
Comparator  Control, active comparator or standard care None 
Outcomes Nutritional behaviour outcomes (e.g. calories 
consumed, number of ONS consumed etc.). 
 
Eating behaviour outcomes (e.g. swallowing, 
use of adapted cutlery). 
 
Weight loss, weight gain, weight maintenance 




RCTs, non-RCTs, or observational cohort 
studies with a control group 
  
Studies without a control group, systematic 
reviews, reviews, opinion pieces, letters, 
commentaries, editorials, preclinical and 
biological studies, and reports published as 
meeting abstracts only with insufficient data 
Language English language Non-English-language  
MND, Motor Neurone Disease;  NDMS,  Neurodegenerative disorders of the motor system; HD, Huntington’s Disease; non-
RCTs, non-randomised trials; PBP, Progressive Bulbar Palsy; PMA, Progressive Muscular Atrophy; PLS, Primary Lateral 






The methodological quality of each included study was assessed using the Cochrane 
Collaboration’s tool for assessing the risk of bias in randomised controlled trials (RCTs)15  
across the following domains: sequence generation (selection bias), allocation sequence 
concealment (selection bias), blinding of participants and personnel (performance bias), 
blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), 
selective outcome reporting (reporting bias) and other potential sources of bias. Each domain 
was rated a being at high, low or unclear risk of bias according to criteria detaile  in the tool. 
The studies were assessed by one reviewer and independently checked by another reviewer. 
 
Data synthesis 
A meta-analysis was not conducted on the data, as the studies were considered to be too 
heterogeneous with regards to the study designs, interventions and types of outcome data 
available. Therefore, as suggested by the guidance produced by the Cochrane Collaboration15 
and the Centre for Reviews and Dissemination for undertaking systematic reviews,16 17 a 
narrative synthesis of included studies was undertaken. Effect sizes were planned to be 
computed for specific BCTs and MODs. However, the small number of studies identified and 
heterogeneity between studies did not provide sufficient data to allow this analysis. 
 
Results 
After removal of duplicates, a total of 4326 records were screened, of which 150 full-text 
articles were considered potentially eligible for inclusion. Following detailed screening 14 
articles18-31 were included in the systematic review. The majority of the excluded articles did 
not relate to oral nutrition or the study design did not include a control group. A summary of 





























Figure 1  
Study selection flow chart (adapted). 
Records identified through database 
searching  




















Additional records identified through other 
sources, including targeted searches, citation 
and reference list searches of reviews and 
included studies (n = 781) 
Full-text articles assessed 
for eligibility  
(n = 150) 
Records screened by title  
(n = 4326) 
Excluded by title  
(n = 3006) 







Full text articles included  
(n = 14 studies) 
Records screened by abstract  
(n = 1320) 
Full-text articles excluded  
(n = 136) 
 
Studies included in quantitative 
synthesis  




Characteristics of included studies  
The characteristics of the 14 included studies are reported in Tables 2 and 3 as well as 
Supplementary Table 1.18-31 All included studies were intervention studies with a control 
group reporting on interventions used to promote oral nutritional behaviours in participants 
with NDMS. Eight studies reported on interventions used to assist with swallowing 
difficulties19 20 22 23 25 26 29 30 and six studies18 21 24 27 28 31 reported on interventions targeting 
dietary content. Of the 14 included studies, two studies20 31 were reported as a conference 
meeting abstract with limited reporting details whilst the remaining studies were available as 
journal articles.  The studies were published between 200822 and 201719 31and were conducted 
in the USA (n = 4),22 26 29 31Australia (n = 2),25 27 Brazil (n = 3),18 19 28 China (n = 1),30 
Germany (n = 1),21 Israel (n = 1),23 Italy (n = 1)24 and Canada (n = 1).20 Care settings 
comprised of clinics/units in eight studies18 19 21 23 24 28-30 and acute-care hospitals and 
subacute residential facilities in four studies.22 26 27 31 Two studies20 25 did not report the 
settings. The size of the studies varied considerably with the number of participants ranging 
from 1628 to 228.22 The mean age of included participants ranged from 50 years25 to 81 
years,26 however in one study20 age was not reported and in another22 the data could not be 
extracted. Six studies included participants with ALS,18 20 21 24 28 31 five studies included 
participants with PD only,19 23 27 29 30 two studies included mixed samples of PD (with or 
without dementia) or dementia only,22 26 and one study included participants with HD.25 
 
Disease stage was only reported in two studies,23 29 both of which assessed PD severity using 
Hoehn and Yahr scale (H&Y), which defines broad categories of motor function in PD. The 
stages range from 0 to 5, with stage 0 indicating no signs of disease and stage 5 indicating the 
need for a wheelchair or an individual is bedbound without assistance. In Manor et al.23 




score ranging from two to four. Site of disease onset in ALS was reported in three studies18 21 
31 with percentage of bulbar onset ranging from 26%18 to 83%.21 Where reported, duration of 
disease ranged from five years25 to 11.8 years.19 
Risk of bias within studies 
All ratings were either for low or unclear risk of bias, with the exception of three high risk 
ratings for the selection bias domains for the non-randomised studies in Ayres et al.19 and 
Wei et al.30 and two high risk ratings for performance bias in Wills et al.31 nd Sheard et al.27 
due to the open labelled nature of the studies in which participants were not blinded 
(Supplementary Table 2). The studies receiving the greatest number of low risk of bias 
ratings (n = 5 for each) were Robbins et al.26 and Troche et al.29 The study by Cleary et al.20 
was a conference meeting abstract with limited reporting and so no further details were 
available to allow the critical appraisal of the methods of this study. 
 
Outcomes and synthesis of results 
Interventions targeting swallowing difficulties 
Six interventions, reported in eight studies19 20 22 23 25 26 29 30 were identified that targeted 
swallowing difficulties (see Table 2); these included: 
 
(i) Chin-down posture or use of thickened liquids 
Three studies19 22 26 in patients with PD disease assessed the effectiveness of the chin-down 
posture in improving swallowing-related outcomes. The chin-down postural manoeuvre is 
performed by lowering the head with the intention of touching the chin with the neck or chest 




displacement of the epiglottis to a more protective position.19 Ayres et al.19 (n=24) compared 
the chin-down posture manoeuvre (intervention group 1) with a non-chin down posture group 
(intervention group 2) and a control group. The chin-down posture manoeuvre group received 
four weekly individual sessions of 30 minutes including training of chin-down manoeuvre 
with saliva and water. They were trained to perform the manoeuvre twice a day, swallowing 
saliva and during meals, throughout the week at home. An orientation group received four 
individual sessions of 30 minutes a week. In these sessions, doubts about the guidelines and 
treatment adherence were verified and instructions about feeding were performed; all 
instructions were given on a written document but the chin-down postural manoeuvre was not 
applied. The control group did not receive any intervention. The use of the chin-down 
postural manoeuvre resulted in significant improvements in clinically-evaluated symptoms of 
dysphagia when swallowing solid and liquid consistencies (p < 0.001 and p = 0.022 
respectively) compared to the other two groups. However, assessment by Fiberoptic 
Endoscopic Evaluation of Swallowing (FEES) did not demonstrate differences between 
groups. Significant differences in symptom frequency and mental health domains of the 
SWAL-QOL were also observed (p = 0.029 and p = 0.004, respectively).  
 
Two further studies, Logemann et al.22 and Robbins et al.,26 in addition to chin-down posture 
manoeuvre also assessed the use of nectar- and honey-thickened liquids (300 Centipoise) in 
improving swallowing difficulties. For the nectar and honey-thickened liquids, the patients 
were instructed to take the food from a spoon, hold the food in their mouths, and then 
swallow it in a head neutral position. For chin-down posture, patients were instructed to put 
their chins down to touch their chests or necks whilst swallowing thin liquid (15 Centipoise). 
Logemann et al.22 (n=228) found that the use of honey-thickened liquids resulted in the 




(54%, p < 0.001) and the use of the chin-down posture (59%, p < 0.0001). Robbins et al.26 
(n=515) reported a similar pattern of aspiration rates in the honey-thickened (61%), nectar-
thickened (65%) and chin-down posture (70%), intervention groups, although differences 
between the groups were non-significant. In addition, the proportion of patients reporting 
weight loss at three months follow-up was similar (2%) in the three groups. Overall, there is 
some evidence that the use of thickened liquids may reduce aspiration and that the chin-down 
posture may help to reduce dysphagia symptoms; however, the small number of studies 
precludes strong conclusions regarding the effectiveness of these interventions.  
 
(ii) Respiratory muscle training 
Two studies (one in PD29 and one in HD25) reported on the effectiveness of respiratory 
muscle training. Troche et al.29 (n=60) used a restorative treatment called expiratory muscle 
strength training (EMST) for swallowing dysfunction, which works by generating increased 
submental musculature force activation which in turn elevates the hyolaryngeal complex. The 
EMST treatment program uses a calibrated, one-way, spring-loaded valve to mechanically 
overload the expiratory and submental muscles. Troche et al.29 assessed the effectiveness of 
EMST in PD with a sham device, which was identical to the EMST device except the 
pressure release valve was made to be non-functional by removing the spring. Participants in 
both groups were visited weekly during the four week training phase by a clinician to remind 
them how to properly use the device and then participants trained independently at home, 
completing five sets of five repetitions, five days per week. Improved swallow safety 
(measured by penetration-aspiration scores) was observed by the EMST intervention 
compared with the sham control group (p = 0.001). Hyolaryngeal function during swallowing 
also improved as a result of the intervention. However, there were no significant differences 




the intervention and control group undertook home-based inspiratory and expiratory muscle 
training (five sets of five repetitions, six times a week for four months) but the intervention 
group had a progressively increased resistance (from 30% to 75% of each patient’s maximum 
respiratory pressure), whereas the control group used a fixed resistance of nine centimetres of 
water throughout the training period. No substantive differences were found between the 
intervention and control groups for any of the measures of swallowing function or 
Swallowing Quality of Life at two or four month follow-up.  
 
(iii ) Lung volume recruitment intervention  
Lung volume recruitment intervention (LVR) - a manual breath stacking technique to help 
patients cough with sufficient force to clear pulmonary secretions - was assessed in a single 
study in people with ALS20 (n=29). The LVR intervention was reported to have a significant 
effect on peak cough flow compared to no treatment. However, this data was from a 
conference meeting abstract with limited reporting. 
 
(iv) Video-assisted swallowing therapy  
A single study23 in participants with PD (n=42) assessed video-assisted swallowing therapy 
(VAST), a therapeutic approach based on the concept that a dynamic personalised video of 
swallowing will help the patient implement instructions. The video depicts the patient’s 
swallowing function during a FEES session at baseline and then a second time while 
implementing the learned compensatory technique (repeated forceful swallow). The analysis 
of VAST was compared with conventional therapy (control) and the only difference between 
the two groups was the implementation of the video-assisted tool during each therapy session. 
VAST significantly improved food residue in the pharynx as assessed by FEES at baseline 




between groups on other measures assessed by FEES (e.g. bolus flow time, bolus location, 
penetration and aspiration). Dysphagia symptoms as measured by the Swallowing 
Disturbance Questionnaire were significantly improved in the VAST group compared with 
the control group immediately post-intervention and at one month follow-up (p < 0.005). The 
SWAL-QoL scores were significantly better in the VAST group compared with the control 
group for burden, eating desire, social functioning, mental health and symptom frequency (p 
< 0.01) with significant improvements observed between four weeks post-therapy and six 
months post-therapy. There was also a significantly greater improvement in the Pleasure of 
Eating score during the course of therapy in the VAST group compared with control group (p 
< 0.05). In addition, Swallowing Quality of Care scores were significantly better in the VAST 
group than the control group immediately post-treatment (p < 0.05). 
 
(v) Swallowing management clinic with outpatient support  
The effectiveness of a swallowing management clinic with outpatient support was assessed in 
one study in PD (n=217).30 The intervention was a standardised out-of-hospital management 
intervention including long-term attention and overall management (establishment of a 
swallowing management clinic, swallowing archives, periodic re-examination with 
individualised intervention strategies), multi-media training combined with feedback to raise 
awareness and education, out-of-hospital rehabilitation training (swallowing skill training, 
oral muscle exercises, mis-inhalation protection, pronunciation, effective cough, pharynx 
cold stimulation and empty swallowing training), eating prescription (guidance on 
appropriate posture, amount per morsel, food property selection', compensatory strategies), 
and a web chat platform to monitor, prompt and educate patients and for patients to ask 
questions. The control group received face and tongue training and eating considerations but 




dysphagia recovery in the intervention group (68.3%) compared with the control group (17%) 
(p < 0.01). The mis-inhalation rate was also observed to be lower in the intervention group 
than in the control group (p < 0.01). 
  
Behavioural change techniques (BCTs) and modes of delivery (MoDs) used in intervention 
studies targeting swallowing difficulties 
The behavioural change techniques (BCTs) and modes of delivery (MoDs) were evaluated in 
all studies apart from the Cleary et al.20 conference abstract which did not contain sufficient 
details to code BCTs or MODs.  
 
A total of eleven different BCTs13 were identified (Supplementary Table 3). The most 
frequently coded BCT was instruction on ‘how to perform the behaviour’,which was 
identified in a total of seven studies19 22 23 25 26 29 30 reporting the use of the chin-down 
posture,20 22 26 thickened liquids,22 26 VAST,23 respiratory muscle training25 29 and swallowing 
management clinic with outpatient support.30 The BCT of ‘behavioural practice/rehearsal’ 
was identified in four studies,23 25 29 30 reporting the use of respiratory muscle training,25 29 
swallowing management clinic with outpatient support30 and VAST.23 ‘Self-monitoring’ was 
also identified in four studies19 23 25 29 reporting the use of chin-down posture,19 respiratory 
muscle training25 29 and VAST.23 ‘Feedback on behaviour’ was reported in two studies29 30 
reporting the use of respiratory muscle training29 and swallowing management clinic with 
outpatient support.30 Other BCTs were only reported in individual studies. There was no 
evidence to link specific BCTs to intervention effectiveness. 
 
Nine different MoDs14 were identified (Supplementary Table 4). The most commonly applied 




use of chin-down posture,19 22 thickened liquids,22 respiratory muscle training,25 29 swallowing 
management clinic with outpatient support30 and VAST.23 ‘Somatic, liquid’ was identified in 
the two studies on thickened liquids.22 26 ‘Somatic, unspecified’ was also reported in the two 
studies on swallowing management clinic with outpatient support30 and respiratory muscle 
training.29 Other MoDs were either reported in individual studies or not reported. There was 




Table 2  
Key characteristics of studies testing interventions targeting swallowing problems.  
Study, 
year 
Diagnosis Study design and 
sample size (N) 
Intervention conditions Control conditions 
 
Outcome measures and 
assessments 






Chin Down Posture Manoeuvre (CD) 
and written instructions regarding 
feeding 
C1: no intervention 
C2: same as intervention but no CD 
manoeuvre training.  
Clinical evaluation  
FEES   
SWAL-QOL 







1. Drink thin liquid in chin-down 
posture (CD)  
2. Drink nectar-thickened liquid (NT) 
with no postural adjustment  
3. Drink honey-thickened liquid (HT) 
with no postural adjustment  
All participants completed all three 
interventions in a randomly assigned order. 











followed until death 
or 3 months 
1. Drink liquids in a chin-down 
posture (CD) 
2. Drink nectar-thickened (NT) liquid 
in a head-neutral position  
3. Drink honey-thickened (HT) liquid 
in a head-neutral position 
Participants were randomly assigned to one 
of the three interventions  
Rates of aspiration assessed 
during intervention 



















Swallow safety (PA score) 
Physiologic measures of 
swallow mechanism (Hyloid 
duration and displacement) 
SWAL-QOL 
Assessed at baseline and after 4 






Inspiratory and respiratory muscle 
training (EMST) – used a 
progressively increased resistance 
Inspiratory and muscle training - same as 
intervention but used a fixed resistance of 
9 cm water 
Swallowing function (assessed 
by water swallowing test) 
SWAL-QOL  
Assessed at baseline, 2 and 4 
months after training 







Lung Volume Recruitment (LVR) No treatment Peak cough flow measure 
Assessed at baseline, 
immediately and 30 minutes 
after treatment 





VAST plus conventional swallowing 
therapy  








Assessed at baseline, 1 and 6 
months follow-up 






clinic with outpatient 
support  
 
Standard care  Dysphagia rehabilitation 
efficiency  
Mis-inhalation incidence rate 
Assessed at 6 month follow-up 
PA, penetration-aspiration; C, control group; CD, Chin Down Posture; EMST,  Expiratory Muscle Strength Training; FEES, Fibreoptic Endoscopic Evaluation of Swallowing; HT, honey-
thick liquids; I, intervention group; LVR, Lung Volume Recruitment; NT, nectar-thick liquid; IG2, intervention group 2; POE, Pleasure of Eating Scale; SDQ, Swallowing Disturbances 





Intervention studies targeting dietary content 1 
Six studies18 21 24 27 28 31were identified that reported on interventions targeting dietary content 2 
(see Table 3), of which four18 24 27 31 reported interventions providing nutritional advice and 3 
support and two21 28 reported interventions providing different supplements. A variety of 4 
methods were used to assess nutritional behaviour. Each included study tested a different 5 
intervention.  6 
 7 
(i) Nutritional advice and support 8 
First, Almeida et al.18 (n=53) compared the use of a food pyramid tool adapted to the 9 
Brazilian population32 with a control group in ALS participants. The food pyramid tool was 10 
used to deliver nutritional education to patients by providing guidelines to patients and 11 
caregivers during quarterly outpatient monitoring, nutritional counselling and periodic 12 
verification of anthropometric measurements and food intake. The tool also helped patients to 13 
monitor their own nutritional status. The control group were provided with general guidelines 14 
including changes in food consistency (i.e. texture) and dividing up the components of meals. 15 
There was an increase in the consumption of dairy products in the intervention group between 16 
baseline and three-month follow-up (p < 0. 05), although consumption data were not reported 17 
for the control group. No statistical difference was found in BMI decline between the control 18 
and intervention group (p = 0.76) at three months follow-up.  19 
 20 
Second, Morassutti et al.24 (n=33) compared the use of a precise nutritional intervention 21 
protocol to monitor participants, with a control group in ALS participants. The estimation of 22 
recommended nutritional requirements (based on Harris-Benedict formula) and patients' diet 23 
history was used to prescribe standard diet. Consistency (i.e. texture) of food was 24 




patients were unable to orally receive adequate calorie intake for their needs from their diet, 26 
oral supplements were recommended and when oral feeding methods could not be used 27 
percutaneous endoscopic gastrostomy was recommended. The intervention group received 28 
nutritional intervention according to a fixed calendar. In the control group, participants 29 
received intervention according to the clinical condition of each patient and were monitored 30 
before the protocol was applied (i.e. when criteria for referral to  nutritionist were not yet 31 
determined nor was monitoring formalised or the work method standardised). The study 32 
found that higher proportions of patients in the intervention group took food by mouth and 33 
oral nutritional supplements, and a lower proportion received enteral nutrition, compared 34 
with the control group at 1, 6 and 12 months follow-up. In addition, weight loss was also 35 
lower in the intervention compared to the control group at all follow-ups.  36 
 37 
Third, Wills et al.31 (n=19) compared an e-health application (iPad or iPhone) or in-person  38 
(i.e. face-to-face) dietary counselling with standard care in patients with ALS.  Participants in 39 
the in-person arm received dietary counselling at every in-person visit and biweekly 40 
telephone calls and/or email follow-ups between visits. Participants in the e-health arm 41 
received biweekly remote dietary counselling and monitoring of dietary intake using the E-42 
health Application To Measure Outcomes REmotely (EAT MORE). The authors30 f und that 43 
both the in-person and e-health nutritional intervention groups had a higher calorie intake 44 
than standard care controls at three months follow-up. However, these differences were not 45 
significant at six months follow-up. The effect of the nutritional interventions on weight was 46 
not reported. 47 
 48 
Fourth, Sheard et al.27 (n=19) investigated the effect of individualised nutrition information 49 




information only) in participants with PD.  Both groups had four visits. Non-significant 51 
differences were found in Parkinson’s Disease Questionnaire-39 scores between participants 52 
who received individualised nutritional advice from dietitian and weekly phone contact 53 
versus standard care at 12-weeks follow-up.  54 
 55 
(ii) Provision of supplements 56 
First, Dorst et al.21 (n=26) compared the use of high fat or high carbohydrate oral food 57 
supplements in addition to normal food intake in people with ALS. Patients took 200 ml of 58 
the food supplement three times daily (3 x 200 ml) between their normal meals for 12 weeks. 59 
Both food supplements had 150 kcal per 100 ml. The food supplement with high fat content 60 
contained 35% fat, 50% carbohydrates, and 15% protein; the supplement with high 61 
carbohydrate content contained 0% fat, 89% carbohydrate, and 11% protein. It was found that 62 
the use of both high fat and high carbohydrate oral food supplements led to significant weight 63 
gain during the 12 weeks intervention period (p = 0.012 and p = 0.0008, respectively), with a 64 
greater effect observed in the group with high fat supplement, although the difference in 65 
weight gain between the two supplements was not statistically significant (p = 0.37). Non-66 
significant differences between the groups were found for all other outcomes (e.g. 67 
cholesterol) apart from a greater increase in body fat in patients receiving the high fat versus 68 
the high carbohydrate oral food supplements (p = 0.035). 69 
 70 
Second, Silva et al.28 (n=16) compared the use of milk whey protein (containing 70% of milk 71 
serum protein and 30% modified starch) oral supplement with a control group using 72 
maltodextrin oral supplement. Nutritional supplementation was administered twice a day 73 




observed for the group receiving milk whey proteins, whereas weight and BMI declined for 75 
the group receiving maltodextrin, but differences between the groups were non-significant.  76 
 77 
Behavioural change techniques (BCTs) and modes of delivery (MoDs) used in intervention 78 
studies targeting dietary content 79 
BCTs and MoDs were coded in all studies apart from the study by Dorst et al.21 which 80 
contained insufficient detail to allow coding of BCTs and MODs. Supplementary Table 4 81 
provides details of the BCTs applied in each intervention. Overall, the most commonly coded 82 
BCTs13 across the studies was instruction on how to perform the behaviour, reported in four 83 
studies.18 24 28 31 The BCT of credible source was reported in two studies.27 31 A total of four 84 
other BCTs were reported in individual studies, including goal setting,31 feedback on 85 
behaviour,31 self-monitoring31 and pharmacological support.24  86 
 87 
Supplementary Table 5 provides details of MODs used in each intervention. The most 88 
frequently identified MoD14 was human, face-to-face reported in three studies24 27 31 and 89 
somatic, liquid reported in two studies.21 28 A total of four other MoDs were reported in 90 
individual studies, including human, distance, audio call,27 digital, phone, email,31 digital, 91 
phone, app31 and somatic (unspecified).24 There was no evidence to link specific BCTs or 92 





Table 3.  
Key characteristics of studies testing interventions targeting dietary content 
Study, 
Year 
Diagnosis Study design and 
sample size (N) 
Intervention condition Control condition 
 
Outcome measures and assessment  






Food pyramid tool (adapted to 
Brazilian population) 
 
General guidelines, including changes 
in food consistency and dividing up 
components of meals 
BMI 
Food intake (food frequency 
questionnaire) 









intervention protocol and received 
nutritional intervention according to 
a fixed calendar 
 
Nutritional intervention according to 
the clinical condition of each patient. 




Types of nutritional intervention 
received (standard diet, ONS, enternal 
feeding)  
Assessed at initial assessment, 1, 6 and 






E-Health application  
OR 
In-person dietary counselling  
Standard Care BMI 
24-hour recalls and 4-day food records  






Individualised nutritional advice 
from dietitian and weekly phone 
contact 



















Supplement with high carbohydrate 
content   
 
 
Body weight  
Blood tests (cholesterol, LDL, HDL 
and triglycerides) 
Fat mass (BIA) 







Milk whey protein oral 
supplements set at 30% of the daily 
protein requirements 
Maltodextrin oral supplements  Weight, BMI 
Assessed at baseline, 2 and 4 months  
BIA, bioelectrical impedance analysis; BMI, body mass index; C, control;  HDL, high density- lipoprotein; I, intervention; LDL, low-density-lipopr tein; NR, not reported; ONS, oral 





In this systematic review, 14 studies18-31 were identified that assessed interventions used to 
promote oral nutritional behaviour in people with NDMS. Of these, eight studies19 20 22 23 25 26 
29 30 reported on interventions used to assist with swallowing difficulties and six 18 21 24 27 28 31 
reported on interventions targeting dietary content. Some positive findings were found for the 
effectiveness of interventions targeting swallowing-related difficulties in NDMS, including 
the use of chin-down posture, thickened liquids, respiratory muscle training, video-assisted 
swallowing theory and swallowing management clinics with outpatient support. However, 
some of the interventions assessed were based on single studies only, and even when 
interventions were evaluated in more than one study, evidence did not allow a definitive 
conclusion on effectiveness to be made. Some potentially promising evidence was also 
identified on interventions targeting dietary content in people with NDMS, although data 
were limited. Positive effects were observed for the use of an individualised nutritional 
intervention protocol, electronic health application and face-to-face dietary counselling, as 
well as well the provision of oral nutritional supplements. However, these results should be 
viewed with caution, as the interventions were only evaluated in single studies and in some 
cases the positive findings were not sustained at longer-term follow-up (6 months).31 In 
addition, the studies testing the provision of oral nutritional supplements21 28  had very small 
sample sizes which is likely to have precluded significant between-group differences due to 
low statistical power.  
 
The identified interventions were also coded for relevant BCTs and MoDs to identify 
components within the intervention that may be associated with increased effectiveness. A 
limited range of BCTs were used in the interventions, with many of the BCTs only reported 




used BCT and was reported in all bar one of the coded studies. This is expected given that the 
interventions tested specific swallowing techniques or provided advice on ways to increase 
calorie intake (e.g. through food fortification or the use of nutritional supplements). Other 
frequently used BCTs included behavioural practice and self-monitoring. The most 
frequently employed MoD was face-to-face by a healthcare professional, although there were 
some instances of the use of digital technologies to deliver interventions. However, there was 
no evidence to link specific BCTs or MoDs to intervention effectiveness.  
 
The current review dovetails with the recent ESPEN guidelines for clinical nutrition in 
neurology34. For example, in ALS, the guidelines highlight the importance of screening and 
monitoring for weight loss, screening for dysphagia and providing advice on modifying food 
texture and protecting airways. The guidelines also recommend increasing calorie intake to 
maintain or increase weight using oral nutritional behaviour (including the use of oral 
nutritional supplements) and, if patients’ nutritional needs are not met, enteral feeding. 
However, the current review highlights that the evidence base for these recommendations, in 
terms of specific interventions that may be used to increase calorie intake and address 
swallowing problems, is small, weak and inconclusive.  
 
In particular, the included evidence had a number of important limitations. First, overall, the 
included studies were heterogeneous in terms of population, intervention, comparators and 
outcomes. The heterogeneity between studies, combined with small number of included 
studies, small sample sizes and limited reporting did not allow the undertaking of any 
statistical analysis including computing effect sizes for specific BCTs and MoDs. Hence, 
uncertainty remains over which interventions were considered to be most effective. Second, it 




effective interventions. The reporting of the content of the interventions was often poor (i.e. 
lacked detail). As a result, it is possible that the interventions may have included other BCTs 
and MoDs that were not reported in the studies. Future studies should be encouraged to report 
intervention protocols in greater detail33 to allow for the thorough identification of BCTs and 
MoDs. Third, most of the studies included in the systematic review included participants with 
PD, HD, and ALS. However, as there were relatively few studies of each disease it was not 
possible to assess whether the effectiveness of the interventions was moderated by disease 
type. As a result the transferability of this review to other NDMSs is questionable. Similarly, 
the study by Robbins et al.25 included patients with PD, PD with dementia and dementia; yet 
patients with dementia may have different needs and risk and may respond differently to 
interventions than those without dementia. However, it was not possible to differentiate 
results for patients with different diagnoses. Fourth, our review only identified interventions 
targeting swallowing difficulties and dietary content, with no studies identified on 
interventions targeting other aspects of nutritional behaviour, such as the use of adapted 
cutlery. Fifth, the oral nutritional interventions targeting dietary content were heterogeneous 
in terms of content, duration, how they were delivered and by whom; moreover, usual care 
often included components of the intervention. Consequently, uncertainties therefore remain 
around the beneficial components of nutritional interventions. These and other limitations 
make it difficult to assess the true magnitude and direction of effect of nutritional 
interventions in people with NDMS. 
 
The systematic review also had a number of strengths. First, most of the included studies 
were of moderate to good methodological quality and, as this systematic review is the first in 
this area, it can be used as a base for further research. A second strength of our review lies in 




undertook the screening, data coding, data extraction and quality assessing of all the studies 
and mapping of BCTs and MoDs of all the interventions. In addition, a published search 
strategy (for reproducibility) has also been included. 
 
Our review highlights the need for additional well-designed RCTs (with sufficient sample 
sizes) focusing on nutritional behaviours of interest (e.g. increased calorie intake) with good 
reporting of details (e.g. on intervention and comparator(s), effectiveness results and 
description of BCTs/MoDs). In addition, studies investigating other aspects of nutritional 
behaviour other than swallowing and dietary choices (e.g. ability to prepare meals) are 
necessary. Other key areas that require further investigation include the following:  (1) the 
moderating effect of disease stage and/or severity of symptoms (i.e. dysphagia) on the 
effectiveness of the intervention to help identify the optimal time for introducing the 
intervention to achieve maximum benefit, (2) the use of long-term follow-up in studies to 
assess whether any benefits of the intervention are sustained over time, (3) the identification 
of the optimal intervention frequency, duration and content to attain most effective outcome, 
and (4) the exploration of acceptability, views and preferences of patients and professionals 
of different interventions. Furthermore, consideration needs to be given to where and by 
whom interventions should be delivered and how they could be implemented into current 
management strategies and services as this may require additional resources and training. 
 
Conclusion 
Despite the limited evidence on the various interventions, and especially specific intervention 
components, to promote oral nutritional behaviour these findings may nonetheless inform the 
development of more effective interventions and strategies to help people with NDMS to 




support shows some promise although further research, with larger samples, is needed to 
demonstrate which interventions, or intervention components, yield most benefit to patients. 
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Example search strategy (Medline)  
Database: Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-Indexed 




1  (optim* nutrition* or nutrition* support* or malnutrition or malnourish* or 
undernutrition or undernourish* or under-nutrition or under-nourish* or underweight or 
((under or los* or maintain* or maintenan*) adj2 (weight or body mass or BMI))).mp. 
(162723) 
2  (((food* or diet*) adj3 (enrich* or fortif*)) or ((protein* or carbohydrate* or fat or 
modular) adj3 supplement*)).mp. (23615) 
3  dietary supplements/ or food, fortified/ (54757) 
4  (((adapt* or modif*) adj2 (cutlery or kni* or fork* or spoon*)) or sip feed* or ONS or 
oral nutrition* supplement* or DEANNA or ((diet* or food or nutrition*) adj3 (fortif* or 
supplement*))).ti,ab. (52438) 
5  (((dietetic or nutritional) adj2 (intervention* or treatment*)) or (modif* adj4 textur*) 
or (food* adj2 texture) or ((monitor* or manag* or safe* or assist* or help* or technique) 
adj3 (dysphag* or swallow*))).mp. (7587) 
6  ((hypercalor* or hyper-calor* or (high or higher)) adj2 (calori* or carb* or 
prote*)).mp. (49112) 




8  exp motor neuron disease/ or als.ti,ab. or (pwALS or pwMND or lateral sclero* or 
motor neuron* disease* or MND or progressive muscular atrophy or progressive bulbar palsy 
or kennedy* disease or lou gehrig* disease).mp. (42532) - TIER 1 
9  Parkinson Disease/ or parkinson*.ab. (102566) 
10  Huntington Disease/ or hunting#on*.mp. (17545) 
11  (progressive supranuclear palsy or progressive supra-nuclear palsy or PSP or Steele-
Richardson-Olszewski syndrome or Guillian-barre syndrome).mp. (7033) 
12  9 or 10 or 11 (121316) - TIER 2 
13  exp Multiple Sclerosis/ or multiple sclerosis.mp. (73230) 
14  (dementia or alzheimer*).mp. (204856) 
15  13 or 14 (275386) - TIER 3 
16  exp patient compliance/ or exp treatment refusal/ (78784) 
17  exp Informed Consent/ (38804) 
18  (((patient* or carer* or caregiver* or care-giver* or family or families or health* 
profession* or care* profession* or nurs* or staff or health visitor* or homecare) adj3 
(attitude* or perception* or perspective* or opinion* or belief* or fear* or view* or 
behavio*)) or nutrition* behavio* or (behavio* adj2 chang*)).mp. (144608) 
19  (compliance or compliant or comply or complies or adher* or fidelity or uptake or up-
take or accept* or consent*).mp. (1184469) 
20  16 or 17 or 18 or 19 (1311794) 
21  (cost effective or effectiveness or efficacy or economic evaluation*).mp. (1085407) 





23  (clinical trial* or cohort stud* or observational stud* or nonrandomi* or non-
randomi* or control* group or control* trial* or control* stud* or prospective or 
retrospective).mp. (3135688) 
24  randomized controlled trial.pt. or randomized.mp. or placebo.mp. (798860) 
25  21 or 22 or 23 or 24 (4304755) 
26  exp animals/ (21538001) 
27  exp humans/ (17080409) 
28  26 not 27 (4457592) 
29  ((1 or 7) and 8) not 28 (566) - TIER 1 
30  29 and 25 (252) - TIER 1 (intervention studies) 
31  ((1 or 7) and 12) not 28 (912) - TIER 2 
32  31 and 25 (340) - TIER 2 (intervention studies) 
33  ((1 or 7) and 15 and 20) not 28 (263) 
34     ((2 or 3 or 4 or 5 or 6) and 15) not 28 (1603) 
35  33 or 34 (1735) - TIER 3 
36  35 and 25 (830) - TIER 3 (intervention studies) 
37  29 or 31 or 35 (2977) - TOTAL WP2.1 









Definitions of identified Behaviour Change Techniques (Michie et al., 2013) 
1.3  Goal setting 
‘Set or agree on a goal defined in terms of a positive outcome of wanted behavior’  
2.1  Monitoring of behaviour by others without feedback 
‘Observe or record behavior with the person’s knowledge as part of a behavior change 
strategy’  
2.2 Feedback on behaviour 
‘Monitor and provide informative or evaluative feedback on performance of the behavior’  
2.3 Self-monitoring 
‘Establish a method for the person to monitor and record their behavior(s) as part of a 
behavior change strategy’  
2.6 Biofeedback 
‘Provide feedback about the body (e.g. physiological or biochemical state) using an external 
monitoring device as part of a behavior change strategy’  
4.1 Instruction on how to perform the behaviour 
‘Advise or agree on how to perform the behavior (includes ‘Skills training’)’ 
5.1 Information about consequences 
‘Provide information (e.g. written, verbal, visual) about health consequences of performing 
the behavior’  
6.1 Demonstration of the behaviour 
‘Provide an observable sample of the performance of the behaviour, directly in person or 
indirectly e.g. via film, pictures, for the person to aspire to or imitate’  




‘Introduce or define environmental or social stimulus with the purpose of prompting or 
cueing the behavior’  
8.1 Behavioural practice / rehearsal 
‘Prompt practice or rehearsal of the performance of the behavior one or more times in a 
context or at a time when the performance may not be necessary, in order to increase habit 
and skill’  
8.7 Graded tasks 
‘Set easy-to-perform tasks, making them increasingly difficult, but achievable, until behavior 
is performed’  
9.1 Credible source 
‘Present verbal or visual communication from a credible source in favour of or against the 
behavior’  
11.1 Pharmacological support 
















Definitions of identified Modes of Delivery (Carey et al., 2017) 
01.01  Human, Face-to-face 
‘Delivery through human contact in which the participant meets a person in real-time, face to 
face’  
01.02  Human, distance (unspecified) 
‘Delivery through human contact in which the participant has contact with a person at a 
distance’  
01.02.01 Human, distance, audio call 
‘Delivery through a telephone call involving audio/voice only’  
01.02.03 Human, distance, text message 
‘Delivery through a written message sent via SMS from a person (i.e. as opposed to 
automated SMS)’  
02  Printed material (unspecified) 
‘Delivery through information produced on paper’  
03  Digital (unspecified) 
‘Delivery through a form of digital technology, including computer, smartphone, tablets, 
television, and wearable or environmental devices’  
03.01.01 Digital, Phone, Email 
‘Delivery through a message sent via electronic messenger to a specific email address’  
03.01.06 Digital, Phone, App 
‘Delivery through a purpose-built stand-alone piece of software designed for a particular 
purpose’  
03.02  Digital, computer /TV 




04  Somatic (unspecified) 
‘Delivery through a device designed to act within the body’  
04.05  Somatic, liquid 





Supplementary Table 1  
Additional patient and study characteristics. 
Study, Year 
Funding  
Setting and Location Population Characteristics 
Mean age, years 
(SD) 




Diagnostic criteria Mean disease 
duration, years (SD) 
Studies targeting swallowing difficulties 
Ayres 201719 
NR 
PD and Movement Disorders 
clinic, Brazil 
I: 62.0 (11.5) 
C1: 62.8 (6.2), 




PD UK PD Brain Bank Criteria I: 10.7 (4.7) 
C1: 11.8 (8.0) 
C2: 8.8 (6.0) 
Logemann 200822 
NR 
Acute-care hospitals and sub-












Acute-care hospitals and sub-
acute residential facilities, 
USA 





PD without D 
30%; PD with D 
20%; D 50%   
Diagnosis by physician  
 
NR 
Troche 201029  
Various fundersb 
Academic centre / outpatient 
clinic, USA 
I: 66.7 (8.9) 
C: 68.5 (10.3) 
I: 16.7% 
C: 26.7% 
PD UK PD Brain Bank Criteria NR 
Reyes 201525  
No funding 
received 
NR, Australia I: 56 (10.2) 




HD Positive genetic test, 
clinically verified disease 
expression 
I: 5 (2.6) 













Manor 201323  
NR 
Movement Disorders Unit, 
Israel 
I: 67.66 (8.26) 
C: 69.86 (9.7) 
43%  PD UK PD Brain Bank Criteria I: 7.43 (4.66) 
C: 8.76 (5.67) 
Wei 201730 
NR 
Outpatient clinic, China I: 71.4 (12.7) 





UK PD Brain Bank Criteria NR 
Studies targeting dietary content 
Almeida 201618 
NR 
Outpatient clinic, Brazil I: 56.8 (10.5) 
C: 54 (10.5) 
I: 48.60 % 
C: 27.80% 
ALS El Escorial Criteria I:360 days (NR) 
C: 315 days(NR) 
Morassutti 201224 
NR 
Outpatient clinic, Italy I: 67.5 (9.8) 
C: 69.8 (6.4) 
I: 25%  
C: 52% 
ALS  NR I: 448 days (305) 

















NR PD  Determined by participants’ 
physician or neurologist and 
self-reported by participant 







 53 (range 32-69)  12.5%  ALS El Escorial Criteria 2 (1) 
Dorst 201321 
Fundingc 
NR, Germany Median (range):  
I: 66.5 (43-80)  
C: 58.5 (44-77) 
42.3% ALS  Revised El Escorial Criteria Median (range) 
I: 18.5 months (2-33) 





Supplementary Table 2 
Risk of bias summary: Judgements of risk of bias for each included study.
Author, year Methodological quality assessment 






















Ayres 201719  H U L U U L L 
Logemann 200822 U U L U L U L 
Manor 201323 U U L L L U L 
Reyes 201525 L L U U L U L 
Robbins 200826 L L L U L U L 
Troche 201029 U U L L L L L 




Almeida 201618 U U U U L U L 
Morassutti 201224 U U U U L U L 
Wills 201731 L U H U U U L 
Sheard 201427 L L H U L L L 
Dorst 201321 U U L U U U L 
Silva 201028 U U L U L U L 






Supplementary Table 3 
Behaviour change techniques (BCTs) applied in intervention studies addressing swallowing 











































































































































































































   
2.
1 
   
2.
2 
   
2.
3 
   
2.
6 
   
4.
1 
   
5.
1 
   
6.
1 
   
7.
1 
   
8.
1 
   
8.
7 




Ayres19 2017 PD   X  X        
Logemann 200822 PD+D     X        
Robbins 200826 PD+D X    X        
Troche 201029 PD  X X  X    X    
Reyes 201525 HD   X  X   X X X   
Cleary 201020 ALS            X 
Manor 201323 PD   X X X    X  X  
Wei 201730 PD  X   X X X  X    
Total N/A 1 2 4 1 7 1 1 1 4 1 1 0 
ALS, Amyotrophic Lateral Sclerosis; D, dementia; HD, Huntington’s Disease; N/A, not applicable; PD, Parkinson’s disease;  






Supplementary Table 4 
Modes of delivery (MoDs) applied in intervention studies addressing swallowing difficulties 









































































































































































































Ayres 201719 PD X    X        
Logemann 200822 PD+D X          X  
Robbins 200826 PD+D           X  
Troche 201029 PD X         X   
Reyes 201525 HD X  X X         
Cleary 201020 ALS            X 
Manor 201323 PD X        X    
Wei 201730 PD X X    X    X   
Total - 6 1 1 1 1 1 0 0 1 2 2 1 
ALS, Amyotrophic Lateral Sclerosis; D, dementia; HD, Huntington’s Disease; N/A, not applicable; PD, Parkinson’s disease;  








Supplementary Table 5 
Behaviour change techniques (BCTs) applied in intervention studies targeting dietary content 



















































































































































































































1.3 2.1 2.2 2.3 2.6 4.1 5.1 6.1 7.1 8.1 8.7 9.1 11.1 





    X       X  
Wills 201731  ALS X  X X  X      X   
Sheard 201427  PD            X   
Dorst 201321  ALS              X 
Silva 201028  ALS      X         
Total 6 1 0 1 1 0 4 0 0 0 0 0 2 1 1 
ALS, Amyotrophic Lateral Sclerosis; D, dementia; HD, Huntington’s Disease; N/A, not applicable; PD, Parkinson’s disease;  PD+D, 







Supplementary Table 6  

















































































































































































































ALS       
  
   X 
Morassutti 
201224  
ALS X      
  
 X   
Wills 201731  





    
Sheard 201427  PD X  X          
Dorst 201321  ALS           X  
Silva 201028  ALS           X  
Total  3 0 1 0 0 0 1 1 0 1 2 1 
ALS, Amyotrophic Lateral Sclerosis; D, dementia; HD, Huntington’s Disease; N/A, not applicable; PD, Parkinson’s disease;  
PD+D, Parkinson’s disease with dementia 
 
 
 
 
